drugset / Trial / NCT02208505

Antitussive Effect of Single-dose Dexmedetomidine With Low-dose Remifentanil Infusion

NCT02208505 ↗

Phase 4 Completed 168 enrolled Yonsei University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

After thyroid surgery, the incidence and severity of coughing is important because it may cause serious complications, such as bleeding in the surgical field, laryngospasm, and cardiovascular disturbance. Several studies have shown that the single-dose of dexmedetomidine is effective for reducing cough and agitation during emergence from general anesthesia. To test the hypothesis that single-dose of dexmedetomidine combined with a low-dose remifentanil infusion during emergence from general anaesthesia could reduce coughing as good as high-dose remifentanil infusion, we will evaluate the efficacy on cough suppression and reduction of side effect of remifentanil using non-inferiority trial.

Timeline

Start
2014-02
Primary completion
2015-07
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg —
Comparator Remifentanil Small molecule 1 ng/ml —
Comparator Remifentanil Small molecule 2 ng/ml —

Indications

No indication recorded.